Tox21_300265

PharmaCompass offers a list of Diclofenac Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Diclofenac Sodium manufacturer or Diclofenac Sodium supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Diclofenac Sodium manufacturer or Diclofenac Sodium supplier.

PharmaCompass also assists you with knowing the Diclofenac Sodium API Price utilized in the formulation of products. Diclofenac Sodium API Price is not always fixed or binding as the Diclofenac Sodium Price is obtained through a variety of data sources. The Diclofenac Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Diclofenac Sodium

Synonyms

Qtg126297q, Voltaren, 15307-79-6, Diclofenac sodium salt, Sodium diclofenac, Prophenatin

Cas Number

15307-79-6

Unique Ingredient Identifier (UNII)

QTG126297Q

About Diclofenac Sodium

A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.

Tox21_300265 Manufacturers

A Tox21_300265 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tox21_300265, including repackagers and relabelers. The FDA regulates Tox21_300265 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tox21_300265 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Tox21_300265 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Tox21_300265 Suppliers

A Tox21_300265 supplier is an individual or a company that provides Tox21_300265 active pharmaceutical ingredient (API) or Tox21_300265 finished formulations upon request. The Tox21_300265 suppliers may include Tox21_300265 API manufacturers, exporters, distributors and traders.

click here to find a list of Tox21_300265 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Tox21_300265 KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Tox21_300265 Drug Master File in Korea (Tox21_300265 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Tox21_300265. The MFDS reviews the Tox21_300265 KDMF as part of the drug registration process and uses the information provided in the Tox21_300265 KDMF to evaluate the safety and efficacy of the drug.

After submitting a Tox21_300265 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Tox21_300265 API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Tox21_300265 suppliers with KDMF on PharmaCompass.

Tox21_300265 Manufacturers | Traders | Suppliers

We have 7 companies offering Tox21_300265

Get in contact with the supplier of your choice:

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.

List of Drug Master Files (KDMF) for Tox21_300265 Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Korea.

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

72 Suppliers

21 USDMF

16 CEP/COS

13 JDMF

7 EU WC

20 KDMF

27 NDC API

42 Listed Suppliers

DEVELOPMENTS

5 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

DOSSIERs // Finished Dosage Forms

469 Dossiers

99 FDA Orange Book

121 Europe

34 Canada

60 South Africa

155 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET, EXTENDED RELEASE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;TOPICAL - 2%

TABLET, DELAYED RELEASE;ORAL - 50MG;0.2MG

TABLET, DELAYED RELEASE;ORAL - 75MG;0.2MG

SOLUTION;TOPICAL - 1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GEL;TOPICAL - 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GEL;TOPICAL - 1%

SOLUTION;INTRAVENOUS - 37.5MG/ML (37.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

48 BASF

38 Kerry

24 Roquette

18 Corel Pharma Chem

16 Microlex e.U

15 Seppic

15 Actylis

14 Ideal Cures Pvt Ltd

12 Sigachi Industries

12 Gangwal Chemicals

11 Nanjing Well Pharmaceutical

11 SPI Pharma

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

10 Boai NKY Pharmaceuticals Ltd

10 Gangwal Healthcare

7 DFE Pharma

6 Lonza Capsugel

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 Vasa Pharmachem

4 Pharmatrans-Sanaq

4 Prachin Chemical

4 DKSH

4 Alcedo Pharmachem

4 Ingredion Pharma Solutions

4 Ulanqab Kema New Material

3 Kima Chemical

3 Doshion Polyscience

3 Aeon Procare

3 Finar

2 The Dow Chemical Company

2 Jai Radhe Sales

2 Evonik

2 Shandong Focus Biotechnology Co., Ltd

2 Lubrizol Life Science Health

2 Nanjing Bold Chemical

2 Seqens

2 Nomisma Healthcare

1 Qianhao Chemical (Hebei) Co., Ltd

1 ACG Worldwide

1 Shanghai Welltone Material Technology Co., Ltd

1 BioSpectra

TABLET, EXTENDED RELEASE;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;TOPICAL - 1.5% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

GEL;TOPICAL - 3% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INTRAVENOUS - 37.5MG/ML (37.5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons